Target intelligence / Profile preview

Polyadenylate-binding protein cytoplasmic 1-like (PABPC1L)

Target
PABPC1L
Molecular classification
RNA-binding protein, Polyadenylate-binding protein family, Other
01

Overview

Polyadenylate-binding protein cytoplasmic 1-like (PABPC1L) is a cytoplasmic RNA-binding protein in the polyadenylate-binding protein type-1 family that binds to the poly(A) tail of mRNA. It plays a fundamental role in translational activation of maternal mRNAs during oocyte maturation and early embryogenesis, especially in vertebrates like humans, mice, and Xenopus. PABPC1L interacts with polyadenylated mRNAs, stabilizing them and enabling efficient translation by displacing translational repressors and promoting assembly of the translational initiation complex (e.g., eIF4G–eIF4E interaction). Loss-of-function or pathogenic mutations in PABPC1L cause oocyte maturation arrest and female infertility, with evidence from both human and animal models. While it is not a direct therapeutic target such as a classical receptor or enzyme, its key role in reproductive biology makes it a potential biomarker or target for infertility-related diagnostics and research. No drugs are currently known to specifically target PABPC1L, and its molecular disruption primarily manifests as impaired oocyte development leading to infertility.

Other names
Poly(A) binding protein cytoplasmic 1-likePABPC1LC20orf119EPABEmbryonic poly(A)-binding proteinPABPC1L1ePABdJ1069P2.3OZEMA22
02

Biological functions

Translational activation of maternal mRNA during oocyte maturation and early embryo developmentmRNA metabolism and stabilityCytoplasmic mRNA poly(A) tail binding and regulationPromoting dissociation of translational repressors and facilitating translation initiation
03

Disease associations

Infertility due to oocyte maturation arrest (female infertility)Other (key regulator in early embryonic development)
04

Safety considerations

Pathogenic loss-of-function variants cause infertility via defective mRNA translation in oogenesis
05

Biomarkers

PABPC1L pathogenic variants as biomarkers for female oocyte maturation arrest or infertilityElevated or abnormal PABPC1L function may be linked with aberrant mRNA translational activation in oocytes

Beyond the preview

Go deeper on Polyadenylate-binding protein cytoplasmic 1-like (PABPC1L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polyadenylate-binding protein cytoplasmic 1-like (PABPC1L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call